DANIEL DAVID RHOADS
Medical Practice in Lubbock, TX

License number
Pennsylvania MT201992
Category
Medicine
Type
Graduate Medical Trainee
Address
Address 2
Lubbock, TX 79413
Pennsylvania

Professional information

Daniel Rhoads Photo 1

Souluble B-N-Acetylglucoseaminidase Based Antibiofilm Compositions And Uses Thereof

US Patent:
2011000, Jan 13, 2011
Filed:
Oct 12, 2007
Appl. No.:
12/445403
Inventors:
Srinivasa Madhyastha - Winnipeg, CA
Nanda Yakandawala - Winnipeg, CA
Purushottam V. Gawande - Winnipeg, CA
Karen Lovetri - Winnipeg, CA
Jeffrey B. Kaplan - Monsey NJ, US
Daniel Rhoads - Lubbock TX, US
Lasha Gogokhia - Lubbock TX, US
Assignee:
Kane Biotech Inc. - Winnipeg
International Classification:
A61K 38/47, A61K 9/14, A61K 38/44, A61P 31/00
US Classification:
424405, 424 9461, 424 944
Abstract:
The present invention provides compositions comprising an antibiofilm enzyme, a soluble β-N-acetylglucosaminidase similar to the dspB gene (DispersinB™), and an antimicrobial for preventing growth and proliferation of biofilm-embedded microorganisms in acute and chronic wounds, and methods of treatment. The invention further provides methods for preparing medical devices, and in particular, wound care devices using DispersinB™-based antimicrobial compositions.


Daniel Rhoads Photo 2

Soluble Beta-N-Acetylglucosaminidase Based Antibiofilm Compositions And Uses Thereof

US Patent:
2012025, Oct 11, 2012
Filed:
Mar 9, 2012
Appl. No.:
13/416793
Inventors:
Srinivasa MADHYASTHA - Winnipeg, CA
Nanda Yakandawala - Winnipeg, CA
Purushottam V. Gawande - Winnipeg, CA
Karen Lovetri - Winnipeg, CA
Jeffrey B. Kaplan - Monsey NJ, US
Daniel Rhoads - Lubbock TX, US
Lasha Gogokhia - Lubbock TX, US
Assignee:
Kane Biotech Inc. - Winnipeg
International Classification:
A61K 38/47, A61P 31/04
US Classification:
424 9461
Abstract:
The present invention provides compositions comprising an antibiofilm enzyme, a soluble β-N-acetylglucosaminidase similar to the dspB gene (DispersinB®), and an antimicrobial for preventing growth and proliferation of biofilm-embedded microorganisms in acute and chronic wounds, and methods of treatment. The invention further provides methods for preparing medical devices, and in particular, wound care devices using soluble β-N-acetylglucosaminidase based antimicrobial compositions.